2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide

C28H29N7O4S — CID 90217141

IUPAC2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide
SMILESCC(C)c1nnc(-c2ccc(NS(=O)(=O)c3ccc4nc(Nc5ccc(N6CCOCC6)cc5)[nH]c4c3)cc2)o1
InChIInChI=1S/C28H29N7O4S/c1-18(2)26-32-33-27(39-26)19-3-5-21(6-4-19)34-40(36,37)23-11-12-24-25(17-23)31-28(30-24)29-20-7-9-22(10-8-20)35-13-15-38-16-14-35/h3-12,17-18,34H,13-16H2,1-2H3,(H2,29,30,31)
InChIKeyNECRGVCQIOIVLK-UHFFFAOYSA-N
MW559.65 g/mol
LogP5.12
Rot. Bonds8

About 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide

2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide (PubChem CID 90217141) has the molecular formula C28H29N7O4S and a molecular weight of 559.65 g/mol. Its IUPAC name is 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide.

Molecular Properties

Compound Name2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide
PubChem CID90217141
Molecular FormulaC28H29N7O4S
Molecular Weight559.65 g/mol
Exact Mass559.20
IUPAC Name2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide
SMILESCC(C)c1nnc(-c2ccc(NS(=O)(=O)c3ccc4nc(Nc5ccc(N6CCOCC6)cc5)[nH]c4c3)cc2)o1
InChIInChI=1S/C28H29N7O4S/c1-18(2)26-32-33-27(39-26)19-3-5-21(6-4-19)34-40(36,37)23-11-12-24-25(17-23)31-28(30-24)29-20-7-9-22(10-8-20)35-13-15-38-16-14-35/h3-12,17-18,34H,13-16H2,1-2H3,(H2,29,30,31)
InChIKeyNECRGVCQIOIVLK-UHFFFAOYSA-N
XLogP5.12
TPSA138.27 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500559.65
LogP ≤ 55.12
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide?
The IUPAC name of 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide (CID 90217141) is 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide.
What is the SMILES notation for 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide?
The canonical SMILES for 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide is CC(C)c1nnc(-c2ccc(NS(=O)(=O)c3ccc4nc(Nc5ccc(N6CCOCC6)cc5)[nH]c4c3)cc2)o1.
What is the InChIKey of 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide?
The InChIKey is NECRGVCQIOIVLK-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H29N7O4S/c1-18(2)26-32-33-27(39-26)19-3-5-21(6-4-19)34-40(36,37)23-11-12-24-25(17-23)31-28(30-24)29-20-7-9-22(10-8-20)35-13-15-38-16-14-35/h3-12,17-18,34H,13-16H2,1-2H3,(H2,29,30,31).
What are the key properties of 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide?
2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide has a molecular weight of 559.65 g/mol, XLogP of 5.12, 8 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-morpholin-4-ylanilino)-N-[4-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)phenyl]-3H-benzimidazole-5-sulfonamide is sourced from PubChem (CID 90217141), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).